粥样硬化-话题@MedSci

#粥样硬化#

450篇内容 | 6358人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1944624, encodeId=30e1194462498, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019, objectType=article, longId=181728, objectId=f1a9181e28e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1a9181e28e8, replyNumber=0, likeNumber=25, createdTime=2020-08-06, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1a9181e28e8, moduleTitle=欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1a9181e28e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944659, encodeId=670c1944659e0, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件, objectType=article, longId=195610, objectId=6c6f195610db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c6f195610db, replyNumber=0, likeNumber=91, createdTime=2021-04-09, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c6f195610db, moduleTitle=Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c6f195610db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944649, encodeId=e6f61944649e9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=JACC：健康人群从40岁开始动脉粥样硬化进程加快, objectType=article, longId=191787, objectId=cbbe191e87ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbbe191e87ca, replyNumber=0, likeNumber=63, createdTime=2020-05-01, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbbe191e87ca, moduleTitle=JACC：健康人群从40岁开始动脉粥样硬化进程加快, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbbe191e87ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944663, encodeId=86bc194466340, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=JAMA：他汀类药物对高龄老年人动脉粥样硬化性心血管疾病一级预防有益, objectType=article, longId=197263, objectId=f49a19e2634c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49a19e2634c, replyNumber=0, likeNumber=83, createdTime=2021-03-05, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49a19e2634c, moduleTitle=JAMA：他汀类药物对高龄老年人动脉粥样硬化性心血管疾病一级预防有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49a19e2634c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944640, encodeId=2b2f194464083, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=2020 EAS共识声明：低密度脂蛋白导致的动脉粥样硬化性心血管疾病的病理生理学、遗传学和治疗见解, objectType=article, longId=188780, objectId=7b4f188e8096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4f188e8096, replyNumber=0, likeNumber=63, createdTime=2021-02-07, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4f188e8096, moduleTitle=2020 EAS共识声明：低密度脂蛋白导致的动脉粥样硬化性心血管疾病的病理生理学、遗传学和治疗见解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4f188e8096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944631, encodeId=49ba194463192, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Sic transl med：血小板通过调节髓系抑制因子加速动脉粥样硬化进展, objectType=article, longId=182639, objectId=13ae1826393e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13ae1826393e, replyNumber=0, likeNumber=68, createdTime=2019-11-21, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13ae1826393e, moduleTitle=Sic transl med：血小板通过调节髓系抑制因子加速动脉粥样硬化进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13ae1826393e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944639, encodeId=708519446390a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Circ Res：BMAL1下调通过增强氧化应激加重牙龈卟啉单胞菌引起的动脉粥样硬化, objectType=article, longId=188648, objectId=3e57188648e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e57188648e0, replyNumber=0, likeNumber=71, createdTime=2020-08-10, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e57188648e0, moduleTitle=Circ Res：BMAL1下调通过增强氧化应激加重牙龈卟啉单胞菌引起的动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e57188648e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944656, encodeId=6415194465661, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Lancet：P2Y12抑制剂 vs 阿司匹林用于脉粥样硬化患者二级预防, objectType=article, longId=193805, objectId=2d31193805d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d31193805d5, replyNumber=0, likeNumber=0, createdTime=2020-09-08, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d31193805d5, moduleTitle=Lancet：P2Y12抑制剂 vs 阿司匹林用于脉粥样硬化患者二级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d31193805d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944655, encodeId=e8df1944655cd, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=估计有2.7亿国人有颈动脉粥样硬化！Lancet子刊研究估计，全球20亿, objectType=article, longId=193773, objectId=ec67193e7374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec67193e7374, replyNumber=0, likeNumber=70, createdTime=2021-02-24, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec67193e7374, moduleTitle=估计有2.7亿国人有颈动脉粥样硬化！Lancet子刊研究估计，全球20亿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec67193e7374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944660, encodeId=c4f71944660dd, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Nat Biotech：定向改造肠道微生物群，可抑制动脉粥样硬化的发生, objectType=article, longId=196354, objectId=a5691963546f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5691963546f, replyNumber=0, likeNumber=74, createdTime=2021-03-21, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5691963546f, moduleTitle=Nat Biotech：定向改造肠道微生物群，可抑制动脉粥样硬化的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5691963546f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944628, encodeId=ff191944628e3, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Eur Respir J：阻塞性睡眠呼吸暂停严重程度与亚临床系统性动脉粥样硬化之间的关系, objectType=article, longId=182256, objectId=3877182256e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3877182256e4, replyNumber=0, likeNumber=86, createdTime=2020-09-26, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3877182256e4, moduleTitle=Eur Respir J：阻塞性睡眠呼吸暂停严重程度与亚临床系统性动脉粥样硬化之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3877182256e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944657, encodeId=1c40194465e93, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Radiology:7T MRI评估颅内动脉粥样硬化会有什么新发现呢？, objectType=article, longId=193858, objectId=8a2c1938585d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2c1938585d, replyNumber=0, likeNumber=118, createdTime=2020-07-08, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2c1938585d, moduleTitle=Radiology:7T MRI评估颅内动脉粥样硬化会有什么新发现呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2c1938585d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944612, encodeId=774e19446124a, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Medicines公司的一年两次PCSK9抑制剂抗动脉粥样硬化达到III期研究的主要目标, objectType=article, longId=178240, objectId=d4021e824003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4021e824003, replyNumber=0, likeNumber=56, createdTime=2020-08-02, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4021e824003, moduleTitle=Medicines公司的一年两次PCSK9抑制剂抗动脉粥样硬化达到III期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4021e824003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944637, encodeId=b557194463ef6, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Cell Death Dis：PARP-1缺失可缓解糖尿病性动脉粥样硬化进展, objectType=article, longId=187770, objectId=5e0018e770ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e0018e770ee, replyNumber=0, likeNumber=135, createdTime=2020-09-20, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e0018e770ee, moduleTitle=Cell Death Dis：PARP-1缺失可缓解糖尿病性动脉粥样硬化进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e0018e770ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944645, encodeId=ccec194464577, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Stroke:颈动脉粥样硬化性斑块特点与脑卒中危险指标的相关性, objectType=article, longId=190194, objectId=43421901947f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43421901947f, replyNumber=0, likeNumber=122, createdTime=2020-08-14, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43421901947f, moduleTitle=Stroke:颈动脉粥样硬化性斑块特点与脑卒中危险指标的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43421901947f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944610, encodeId=495619446101c, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Neurosurgery：『首过效应』诊断颅内动脉粥样硬化性闭塞的意义, objectType=article, longId=177309, objectId=09221e7309c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09221e7309c5, replyNumber=0, likeNumber=91, createdTime=2019-11-01, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09221e7309c5, moduleTitle=Neurosurgery：『首过效应』诊断颅内动脉粥样硬化性闭塞的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09221e7309c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944658, encodeId=7aae194465834, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=OCC 2020 | 聚焦降脂，寻找动脉粥样硬化诊疗新策略, objectType=article, longId=194999, objectId=d8a6194999d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a6194999d9, replyNumber=0, likeNumber=70, createdTime=2020-06-25, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a6194999d9, moduleTitle=OCC 2020 | 聚焦降脂，寻找动脉粥样硬化诊疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a6194999d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944605, encodeId=610b1944605fa, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Int J Impot Res：阴茎勃起功能障碍与动脉粥样硬化关系的新证据, objectType=article, longId=175543, objectId=9f021e554305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f021e554305, replyNumber=0, likeNumber=79, createdTime=2019-12-13, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f021e554305, moduleTitle=Int J Impot Res：阴茎勃起功能障碍与动脉粥样硬化关系的新证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f021e554305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944625, encodeId=7614194462503, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019, objectType=article, longId=181729, objectId=a735181e29dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a735181e29dc, replyNumber=0, likeNumber=0, createdTime=2020-02-03, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a735181e29dc, moduleTitle=欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a735181e29dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944630, encodeId=735f194463053, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=欧洲血脂指南主席：动脉粥样硬化性心血病的降脂治疗，强调早期、强化和联合三原则, objectType=article, longId=182321, objectId=f5bb182321e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5bb182321e3, replyNumber=0, likeNumber=68, createdTime=2020-07-26, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5bb182321e3, moduleTitle=欧洲血脂指南主席：动脉粥样硬化性心血病的降脂治疗，强调早期、强化和联合三原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5bb182321e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

粥样硬化

2020-05-29

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019

2020-08-06

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件

2021-04-09

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

JACC：健康人群从40岁开始动脉粥样硬化进程加快

2020-05-01

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

JAMA：他汀类药物对高龄老年人动脉粥样硬化性心血管疾病一级预防有益

2021-03-05

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

2020 EAS共识声明：低密度脂蛋白导致的动脉粥样硬化性心血管疾病的病理生理学、遗传学和治疗见解

2021-02-07

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Sic transl med：血小板通过调节髓系抑制因子加速动脉粥样硬化进展

2019-11-21

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Circ Res：BMAL1下调通过增强氧化应激加重牙龈卟啉单胞菌引起的动脉粥样硬化

2020-08-10

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Lancet：P2Y12抑制剂 vs 阿司匹林用于脉粥样硬化患者二级预防

2020-09-08

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

估计有2.7亿国人有颈动脉粥样硬化！Lancet子刊研究估计，全球20亿

2021-02-24

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Nat Biotech：定向改造肠道微生物群，可抑制动脉粥样硬化的发生

2021-03-21

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Eur Respir J：阻塞性睡眠呼吸暂停严重程度与亚临床系统性动脉粥样硬化之间的关系

2020-09-26

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Radiology:7T MRI评估颅内动脉粥样硬化会有什么新发现呢？

2020-07-08

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Medicines公司的一年两次PCSK9抑制剂抗动脉粥样硬化达到III期研究的主要目标

2020-08-02

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Cell Death Dis：PARP-1缺失可缓解糖尿病性动脉粥样硬化进展

2020-09-20

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Stroke:颈动脉粥样硬化性斑块特点与脑卒中危险指标的相关性

2020-08-14

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Neurosurgery：『首过效应』诊断颅内动脉粥样硬化性闭塞的意义

2019-11-01

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

OCC 2020 | 聚焦降脂，寻找动脉粥样硬化诊疗新策略

2020-06-25

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Int J Impot Res：阴茎勃起功能障碍与动脉粥样硬化关系的新证据

2019-12-13

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

欧洲动脉粥样硬化协会主席解读EAS/ESC2019血脂异常管理指南｜GW-ICC2019

2020-02-03

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

欧洲血脂指南主席：动脉粥样硬化性心血病的降脂治疗，强调早期、强化和联合三原则

2020-07-26

科室
- - 订阅+
  - 更多科室
工具
服务